Prostate cancer decisions — 2019

The Veteran's prostate cancer with stress incontinence is rated at 60 percent effective from February 10, 2016. The PTSD with alcohol dependence claim was denied.

The Veteran's prostate cancer residuals are rated at 60 percent, and the Board has remanded for further examination of his erectile dysfunction.

The Veteran's claims for service connection for renal cancer and prostate cancer are being remanded due to the submission of new evidence that relates to an unestablished fact necessary to substantiate his claims.

The Board denied the Veteran's petition to reopen his claim of service connection for a prostate disability due to lack of new and material evidence, as the submitted evidence was cumulative or redundant of previous records.

The Veteran's prostate cancer and erectile dysfunction claims are denied as there is no evidence of in-service exposure to herbicides, the conditions did not manifest within one year post-service, and there is insufficient evidence linking the current conditions to service.

The Board has decided that the Veteran's claim for a compensable rating for erectile dysfunction associated with prostate cancer status post hormone shots needs to be remanded due to the need for additional private treatment records.

The Veteran's claim for an earlier effective date for his service-connected prostate cancer is denied as there was no prior informal or formal claim filed before August 11, 2016.

The Veteran's cause of death, squamous cell carcinoma, was not related to his active service and is not considered a result or proximately due to any service-connected disability.

The Veteran's sciatica of the left lower extremity is granted service connection as secondary to his service-connected lumbar spine arthritis. The Veteran's prostate disorder, including residuals from prostate cancer, and hip disorders are denied due to lack of evidence showing in-service onset or continuity of symptoms.

The Board has remanded the claims due to new evidence submitted by the Veteran, and requests for VA treatment records. The issues of entitlement to an initial compensable rating for erectile dysfunction and a disability rating in excess of 60 percent for prostate cancer residuals are being reviewed.

The Board denied the Veteran's claim for service connection for prostate cancer as secondary to herbicide exposure, finding that there was no evidence of Agent Orange exposure and that prostate cancer did not manifest within one year of separation.

The Veteran's claims for service connection for various conditions have been denied, and no effective date earlier than August 6, 2013 has been granted.

The Board has remanded the claims for bladder and prostate cancer due to herbicide exposure, as it is not clear if the Veteran currently has these conditions or their residuals. The VA will conduct examinations to determine this.

The Veteran's service-connected disabilities, including prostate cancer, bilateral tinnitus, bilateral sensorineural hearing loss, and erectile dysfunction, do not render him unemployable. The Board denied his claim for a TDIU.

The Board has reopened the Veteran's claims for service connection for prostate cancer, diabetes mellitus, type II, and cerebral vascular disease as due to exposure to herbicides. The appeals are remanded for further development.